Literature DB >> 984811

Josamycin and rosamicin: in vitro comparisons with erythromycin and clindamycin.

S Shadomy, M Tipple, L Paxton.   

Abstract

The macrolide antibiotics josamycin and rosamicin were compared in vitro with erythromycin for activity against Staphylococcus aureus, S. epidermidis, and enterococci and with clindamycin for activity against a variety of anaerobic organisms. Rosamicin and erythromycin were similar in activity and superior to josamycin against aerobic cocci. Most isolates of S. aureus (96%), S. epidermidis (79%), and the enterococci (87%) were inhibited by 1.56 mug of either of the new macrolide compounds per ml. Clindamycin was the most active compound against the anaerobic organisms.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 984811      PMCID: PMC429829          DOI: 10.1128/AAC.10.4.773

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  4 in total

1.  Rosamicin: in vitro activity against anaerobes and comparison with erythromycin.

Authors:  V L Sutter; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1976-02       Impact factor: 5.191

2.  Antibiotic sensitivity testing. Report of an international collaborative study.

Authors:  H M Ericsson; J C Sherris
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

3.  Rosamicin: evaluation in vitro and comparison with erythromycin and lincomycin.

Authors:  C C Crowe; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1974-03       Impact factor: 5.191

4.  Prosthetic valvular endocarditis. A 12-year review.

Authors:  L Slaughter; J E Morris; A Starr
Journal:  Circulation       Date:  1973-06       Impact factor: 29.690

  4 in total
  5 in total

Review 1.  Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part II).

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Clin Pharmacokinet       Date:  1989-05       Impact factor: 6.447

2.  In vitro activity of rosamicin and erythromycin against a group of nonfermenting gram-negative bacilli.

Authors:  J R DiPersio; T L Krafczyk
Journal:  Antimicrob Agents Chemother       Date:  1978-08       Impact factor: 5.191

3.  In vitro susceptibility of 30 strains of Chlamydia trachomatis to rosamicin.

Authors:  T F Smith; H E Washton
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

4.  In vitro susceptibility of Ureaplasma urealyticum to rosaramicin.

Authors:  T F Smith
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

5.  Quantitative nasal cultures from carriers of Staphylococcus aureus: effects of oral therapy with erythromycin, rosamicin, and placebo.

Authors:  S Z Wilson; R R Martin; M Putman; S B Greenberg; R J Wallace; J G Jemsek
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.